Cite
HARVARD Citation
O'Sullivan, J. et al. (n.d.). 2561 Effects of concomitant use of abiraterone and/or enzalutamide with radium-223 on safety and overall survival in metastatic castration-resistant prostate cancer (mCRPC) patients treated in an international early access program (EAP). European journal of cancer. pp. S497-S498. [Online].